Siouxland Hematology-Oncology Associates Llp entered the industry of Oncologists in 1980 and has grown to employ 1 to 4 people, generating an annual revenue of $20.000.000 to $49.9999.999. The NAICS classifies this business under the code 621111, which describes it as a Oncologists. For further clarification, the SIC classifies this business under the code 8011 and described it as a Oncologists. The business provides service to the B2C market.
To acquire more information, please contact Donald B Wender by calling (712) 252-9303 during business hours. You can also write to the business’ Single Location at 230 Nebraska St, Sioux City, Iowa IA 51101. You can also visit the company’s website at nylencancercenter.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Siouxland Hematology-Oncology Associates Llp |
| Representative: | Donald B Wender |
| Place of Business: | 230 Nebraska St, Sioux City, IA 51101 |
| Contact Number: | (712) 252-9303 |
| Website: | nylencancercenter.com |
| Type of Service: | Oncologists |
| SIC Number: | 8011 |
| NAICS Number: | 621111 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Began: | 1980 |
| Income/Year: | $20.000.000 to $49.9999.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Siouxland Hematology-Oncology Associates Llp is a company operating from Woodbury, Iowa providing professional Oncologists and relevant B2C variables. It was founded in 1980 and registered with the SIC code 8011 as Oncologists, and with the NAICS code 621111 as Oncologists.
With a current employee count of 1 to 4, Siouxland Hematology-Oncology Associates Llp has gone to report making $20.000.000 to $49.9999.999 per annum on its journey towards growth. This company invites you to contact its representative Donald B Wender at (712) 252-9303 for related queries, or to locate its Single Location using the coordinates 42.492516,-96.40324.
The Single Location can also be found at the street address 230 Nebraska St in Sioux City, Iowa 51101 and can be engaged online through the company website at nylencancercenter.com, the company Twitter , and Facebook page .